INTC vs NVCT · rev $29.70B vs $304.5M cap
Intel Corporation (INTC) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
NVCT does not have a complete income-statement cache yet.
INTC currently screens at market cap $498.43B. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the INTC and NVCT stock pages for the full models.
Not investment advice.